Cortical vasoactive intestinal peptide in relation to dementia in Parkinson's disease.
作者信息
Jegou S, Javoy-Agid F, Delbende C, Ruberg M, Vaudry H, Agid Y
出版信息
J Neurol Neurosurg Psychiatry. 1985 Aug;48(8):842-3. doi: 10.1136/jnnp.48.8.842.
Abstract
摘要
相似文献
1
Cortical vasoactive intestinal peptide in relation to dementia in Parkinson's disease.帕金森病中与痴呆相关的皮质血管活性肠肽
J Neurol Neurosurg Psychiatry. 1985 Aug;48(8):842-3. doi: 10.1136/jnnp.48.8.842.
2
Laminar degeneration of frontal and temporal cortex in Parkinson disease dementia.帕金森病痴呆患者额叶和颞叶皮质的层状变性。
Neurol Sci. 2017 Apr;38(4):667-671. doi: 10.1007/s10072-017-2828-6. Epub 2017 Feb 8.
3
Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson's disease.
Ann Neurol. 1990 Jul;28(1):57-64. doi: 10.1002/ana.410280111.
4
Pathways to primary neurodegenerative disease.原发性神经退行性疾病的发病途径。
Mayo Clin Proc. 1999 Aug;74(8):835-7. doi: 10.4065/74.8.835.
5
Spectroscopic changes associated with mild cognitive impairment and dementia in Parkinson's disease.与帕金森病轻度认知障碍和痴呆相关的光谱变化。
Dement Geriatr Cogn Disord. 2012;34(5-6):312-8. doi: 10.1159/000345537. Epub 2012 Dec 3.
6
[Inferior frontal region hypoperfusion in Parkinson disease with dementia].[帕金森病伴痴呆患者的额下区域灌注不足]
Neurol Neurochir Pol. 2003;37 Suppl 5:133-44.
7
Untangling a role for tau in synucleinopathies.理清tau蛋白在突触核蛋白病中的作用。
Biol Psychiatry. 2015 Nov 15;78(10):666-7. doi: 10.1016/j.biopsych.2015.08.020.
8
Cortical muscarinic receptors in demented patients with Alzheimer's disease or Parkinson's disease.患有阿尔茨海默病或帕金森病的痴呆患者的皮质毒蕈碱受体。
Br J Pharmacol. 1989 Dec;98 Suppl:817P.
9
Anomalies occurring in lipid profiles and protein distribution in frontal cortex lipid rafts in dementia with Lewy bodies disclose neurochemical traits partially shared by Alzheimer's and Parkinson's diseases.路易体痴呆患者额叶皮质脂筏中脂质谱和蛋白质分布出现的异常揭示了阿尔茨海默病和帕金森病部分共有的神经化学特征。
Neurobiol Aging. 2017 Jan;49:52-59. doi: 10.1016/j.neurobiolaging.2016.08.027. Epub 2016 Sep 6.
10
Decrease of serotonin-S2 receptors in temporal cortex of patients with Parkinson's disease and progressive supranuclear palsy.帕金森病和进行性核上性麻痹患者颞叶皮质中5-羟色胺-S2受体的减少。
Mov Disord. 1988;3(3):255-62. doi: 10.1002/mds.870030310.
本文引用的文献
1
Reduced cortical choline acetyltransferase activity in senile dementia of Alzheimer type is not accompanied by changes in vasoactive intestinal polypeptide.阿尔茨海默型老年痴呆症患者大脑皮质中胆碱乙酰转移酶活性降低，但血管活性肠肽并未发生变化。
Brain Res. 1980 Nov 10;201(1):249-53. doi: 10.1016/0006-8993(80)90795-7.
2
Muscarinic binding and choline acetyltransferase activity in Parkinsonian subjects with reference to dementia.帕金森病患者中与痴呆相关的毒蕈碱结合及胆碱乙酰转移酶活性
Brain Res. 1982 Jan 28;232(1):129-39. doi: 10.1016/0006-8993(82)90615-1.
3
A subcortico-cortical cholinergic system is affected in Parkinson's disease.帕金森病会影响皮质下-皮质胆碱能系统。
Brain Res. 1983 Dec 12;288(1-2):213-8. doi: 10.1016/0006-8993(83)90096-3.
4
Somatostatin and dementia in Parkinson's disease.
Brain Res. 1983 Nov 14;278(1-2):376-9. doi: 10.1016/0006-8993(83)90277-9.
5
Co-localization of vasoactive intestinal peptide (VIP) and enkephalins in chromaffin cells of the adrenal gland of amphibia. Stimulation of corticosteroid production by VIP.两栖类肾上腺嗜铬细胞中血管活性肠肽（VIP）与脑啡肽的共定位。VIP对皮质类固醇生成的刺激作用。
Life Sci. 1983 Jan 24;32(4):375-83. doi: 10.1016/0024-3205(83)90083-8.
6
Dementia in Parkinson's disease.
Acta Neurol Scand. 1976 Nov;54(5):431-41. doi: 10.1111/j.1600-0404.1976.tb04375.x.
7
Dementia in Parkinson disease: a neuropathologic study.
Neurology. 1979 Sep;29(9 Pt 1):1209-14. doi: 10.1212/wnl.29.9_part_1.1209.
8
Vasoactive intestinal polypeptide (VIP): distribution in normal human brain and in Huntington's disease.血管活性肠肽（VIP）：在正常人类大脑及亨廷顿舞蹈病中的分布
Brain Res. 1979 Sep 7;173(1):174-8. doi: 10.1016/0006-8993(79)91109-0.
9
Necropsy evidence of central cholinergic deficits in senile dementia.老年痴呆症中枢胆碱能缺陷的尸检证据。
Lancet. 1977 Jan 22;1(8004):189. doi: 10.1016/s0140-6736(77)91780-9.
Zotero 插件